Abstract
Active smoking is associated with increased thrombosis risk and enhanced efficacy of clopidogrel therapy vs placebo. Prasugrel metabolism is not influenced by smoking and has superior pharmacodynamic efficacy, but its relationship to clinical outcomes has not been evaluated in medically managed ACS
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
